"L’Institut de Cancérologie Paris Nord est l'un des centres de référence en radiothérapie du Val d’Oise (95). Il se situe à Sarcelles, au sein d’un important complexe médical, et collabore avec plusieurs établissements privés du territoire pour assurer la prise en charge en chirurgie, chimiothérapie et soins de suite en cancérologie."

During the past decade, GCS RISSA - Institut de cancérologie Paris Nord conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GCS RISSA - Institut de cancérologie Paris Nord" #1 collaborator was "National Cancer Institute, France" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "GCS RISSA - Institut de cancérologie Paris Nord" are "Bone Metastases" (1 trials), "Breast Cancer Stage IV" (1 trials), "Metastatic Breast Cancer" (1 trials), "Metastatic Lung Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "GCS RISSA - Institut de cancérologie Paris Nord" in a lesser frequency.

Most popular intervention types in "GCS RISSA - Institut de cancérologie Paris Nord" are "Drug" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Palbociclib" (1 trials), "SBRT" (1 trials) and "locoregional treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "GCS RISSA - Institut de cancérologie Paris Nord" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "GCS RISSA - Institut de cancérologie Paris Nord". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GCS RISSA - Institut de cancérologie Paris Nord, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GCS RISSA - Institut de cancérologie Paris Nord, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".